|
About us | Research | Collaboration |
| Molecular diagnostics product | Indication colorectal cancer | Clinical utility | Diagnostics product | |||||
| Research | FFPE product development | LDT | ||||||
| C01-TFunctionalProg | stage II CRC prognosis |
stage II colorectal cancer recurrence risk test and select effective personalized adjuvant drugs |  |
|||||
| C02-FolfoxResponse | stage II,III,IV CRC drug response |
screen personalized alternative treatments for subgroups of FOLFOX resistant colorectal cancer | |
|||||
| C03-TmePre | MSS stage II,III,IV CRC drug response |
colorectal cancer immunotherapy response test | |
|||||